Clinical Trial Update: To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea [Phase 3]

View source ↗

Summary

The sponsor has withdrawn a Phase 3 trial evaluating YAZ for the treatment of Dysmenorrhea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• YAZ (DROSPIRENONE AND ETHINYL ESTRADIOL)

Snippet

Sponsor: Bayer | Conditions: Dysmenorrhea | Phase 3 | Status: WITHDRAWN